Methicillin susceptible Staphylococcus aureus bacteremia: Epidemiology and prognostic factors. A prospective study 2000-2003;Bacteriemias por Staphylococcus aureus sensible a meticilina: Epidemiología y factores pronósticos. Estudio prospectivo 2000-2003

Revista Clinica Espanola

Volumn 207, Issue 2, 2007, Pages 57-63

  Gomez J ^a   Garcia Vazquez E ^a   Banos R ^a   Canteras, M ^b   Ruiz, J ^a   Herrero, J A ^a   Banos V ^a   Valdes M ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Bacteremia; Methicillin susceptible; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ACUTE DISEASE; ADULT; ARTICLE; BACTEREMIA; CLINICAL FEATURE; COMMUNITY CARE; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SURGICAL WARD; TREATMENT OUTCOME; URINE CATHETER;

EID: 33947523764     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13100196     Document Type: Article

References (30)

1. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective Multicenter Study of S. aureus Bacteraemia. Incidence of Endocarditis, Risk Factors for Mortality, and Clinical Impact of Methicillin Resistance. Medicine. 2003;82:322-32.
2. Vaqué J y Grupo de trabajo Epine 2004. Evolución de la prevalencia de las infecciones nosocomiales en hospitales españoles. Epine 1990-2003: 14 años. Madrid: Sociedad Española de medicina preventiva, Salud Pública e Higiene; 2004.
3. Garnes JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
4. Libman H, Arbeit RD. Complications associated with S. aureus bacteremia. Arch Intern Med. 1984;144:541-5.
5. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, et al. Infective Endocarditis. Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation. 2005;111:e394-e433.
6. McCabe WR, Jackson GG. Gram negative bacteremia. Etiology and ecology. Arch Intern Med. 1962;110:847-55.
7. Winston DJ, Murphy W, Young LS, Hewitt WL. Piperacillin therapy for serious bacterial infections. Am J Med. 1980;69:255-61.
8. Gómez J, Casas I, Ruiz J, Campillo V, Pérez B, Sánchez F. Bacteriemias por S. aureus en un hospital general. An Med Interna. 1990;7(3):133-7.
9. Franklin D, Lowy MD. Staphylococcus aureus Infections. NEJM. 1998;339(8):520-32.
10. Chambers HF. The changing epidemiology of S. aureus. Emerg Infect Dis. 2001;7:178-82.
11. Rubio M, Romero J, Corral O, Roca V, Picazo JJ. Bacteriemia por Staphylococcus aureus: análisis de 311 episodios. Enferm Infecc Microbiol Clin. 1999;17:56-64.
12. Matas L, Marti C, Morera MA, Sierra M, Vilamala A, Corcoy F. Bacteremia in 13 general hospitals of the province of Barcelona. Prospective study of 1.674 episodes. Group of Microbiologists of the County Hospitals of Catalonia. Enferm Infecc Microbiol Clin. 1995;13(6):345-55.
13. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin susceptible S. aureus primary bacteremia: At Wath Cost. Infection Control and Hospital Epidemiology. 1999;20:408-11.
14. Mylotte JM, Mc Dermott C, Spooner J. Prospective study of 114 consecutive episodes of S. aureus bacteremia. Rev Infect Dis. 1987;9:891-907.
15. Pahissa A, Capdevilla JA, Almirante B. Bacteriemia por Staphylococcus aureus en un Hospital Universitario. Enf Inf Microbiol Clin. 1988; 6(3):77-88.
16. Tuazon CU, Cardella TA, Sheagren JN. Staphylococcal endocarditis in drug users. Arch Intern Med. 1975;135:1555-61.
17. Finkelstein R, Sobel JD, Nagler A, Merzbach D. S. aureus bacteremia and endocarditis: comparison of nosocomial and community acquired infection. J Med. 1984;15:193-211.
18. Mirimanoff RO, Glauser MP. Endocarditis during Staphylococcus aureus septicemia in a population of non-drug addicts. Arch Intern Med. 1982;142:1311-3.
19. Mylotte JM, Mc Dermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9:891-907.
20. Blot S, Vandewoude K, Hoste E, Colardyn F. Attributable mortality in critically ill patients with bacteremia involvin methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Inter Med. 2002;162:2229-35.
21. Cosgrove SE, Sakoulas G, Perencevich EN, Schawer MJ, Karchmer AW. Comparison of mortality associated with meticillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis. 2003;36:53-9.
22. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired S. aureus bacteremia. Clin Infect Dis. 2003;36(11):1418-23.
23. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244:379-86.
24. Kollef MH, Ward S, Sherman G, Prentice D, Schaiff R, Huey W. et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000;28:3456-64.
25. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-55.
26. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of S. aureus bacteraemia. A prospective study of 278 cases. Arch Inter Med. 2002;162:25-32.
27. González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clinical Infectious Diseases. 1999;29:1171-7.
28. Turnidge J, Chang FY, Fowler VG, Rao N. Staphylococcus aureus. En: Yu VL, Webar R, Raoult D, editors. Antimicrobial Therapy and Vaccines. Volume:1. New York: Apple Trees Productions LLC. Second Edition; 2002. p. 631-58.
29. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother. 1990; 34:1227-31.
30. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera V, Kollef MH. Analysis of Two Double-Blind Studies of patients With Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia. Chest. 2003;124:1789-97.